Reported by Committee — Oct 6, 2015
Last Action: Placed on the House Calendar, Calendar No. 63.
Explanation: The committees assigned to this resolution sent it to the House or Senate as a whole for consideration on October 6, 2015.
Sep 25, 1992
102nd Congress, 1991–1992
This bill was introduced on September 25, 1992, in a previous session of Congress, but was not enacted.
Representative for California's 27th congressional district
9/25/1992--Introduced.Amends Federal patent law to permit separate patent extensions for certain drug products: (1) under a patent which is subject to full regulatory review and approval; and (2) which were ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 6038”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 6038 — 102nd Congress: To amend title 35, United States Code, to permit separate patent extensions for each product .... Retrieved from https://www.govtrack.us/congress/bills/102/hr6038
“H.R. 6038 — 102nd Congress: To amend title 35, United States Code, to permit separate patent extensions for each product ....” www.GovTrack.us. 1992. October 7, 2015 <https://www.govtrack.us/congress/bills/102/hr6038>
|title=H.R. 6038 (102nd)
|accessdate=October 7, 2015
|author=102nd Congress (1992)
|date=September 25, 1992
|quote=To amend title 35, United States Code, to permit separate patent extensions for each product ...